LivaNova PLC (NASDAQ:LIVN) Shares Sold by Great Lakes Advisors LLC

Great Lakes Advisors LLC lowered its position in LivaNova PLC (NASDAQ:LIVN - Free Report) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 279,403 shares of the company's stock after selling 9,862 shares during the quarter. Great Lakes Advisors LLC owned about 0.51% of LivaNova worth $12,939,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Atria Investments Inc grew its holdings in shares of LivaNova by 6.2% in the third quarter. Atria Investments Inc now owns 5,653 shares of the company's stock worth $297,000 after purchasing an additional 331 shares during the last quarter. Central Pacific Bank Trust Division grew its holdings in LivaNova by 21.2% during the 4th quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company's stock worth $191,000 after acquiring an additional 720 shares in the last quarter. Amalgamated Bank grew its holdings in LivaNova by 3.0% during the 4th quarter. Amalgamated Bank now owns 24,900 shares of the company's stock worth $1,153,000 after acquiring an additional 729 shares in the last quarter. Rhumbline Advisers grew its holdings in LivaNova by 0.5% during the 4th quarter. Rhumbline Advisers now owns 177,938 shares of the company's stock worth $8,240,000 after acquiring an additional 899 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its holdings in LivaNova by 29.1% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,311 shares of the company's stock worth $292,000 after acquiring an additional 1,424 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Remove Ads

LivaNova Stock Performance

NASDAQ LIVN traded up $0.68 on Friday, hitting $39.24. 514,589 shares of the company's stock traded hands, compared to its average volume of 639,288. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46. LivaNova PLC has a 1-year low of $36.85 and a 1-year high of $64.47. The firm's 50-day moving average price is $46.00 and its two-hundred day moving average price is $49.07. The firm has a market capitalization of $2.13 billion, a PE ratio of 93.43 and a beta of 1.10.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. StockNews.com cut shares of LivaNova from a "strong-buy" rating to a "buy" rating in a report on Wednesday, February 26th. The Goldman Sachs Group dropped their target price on shares of LivaNova from $64.00 to $55.00 and set a "buy" rating on the stock in a report on Monday, March 3rd. Barclays dropped their target price on shares of LivaNova from $58.00 to $56.00 and set an "equal weight" rating on the stock in a report on Friday, March 7th. Needham & Company LLC dropped their target price on shares of LivaNova from $75.00 to $64.00 and set a "buy" rating on the stock in a report on Wednesday, February 26th. Finally, Mizuho decreased their price target on shares of LivaNova from $70.00 to $60.00 and set an "outperform" rating for the company in a research report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $61.17.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.